InflaRx Aktie

InflaRx für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2H7A5 / ISIN: NL0012661870

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
22.05.2020 09:01:26

Stock Alert: InflaRx N.V Continues To Trend Higher

(RTTNews) - Shares of clinical-stage biopharmaceutical company InflaRx N.V. (IFRX) were up $0.62 or 7.77% Thursday before closing at $8.60. It has traded in the range of $2.17- $42.99 in the last 52-weeks.

Yesterday, InflaRx has reported first-quarter results and updated about the ongoing clinical studies.

The company's lead product candidate is IFX-1, a monoclonal anti-C5a antibody, designed to inhibit the biological activity of C5a. A phase II study of IFX-1 in COVID-19 patients with severely progressed pneumonia is underway. Preclinical data showed that IFX-1 exhibited the ability to control the inflammatory response-related tissue and organ damage via a selective blockade of C5a in the adaptive, randomized, controlled trial.

In March, the company had received positive data from two initial Covid-19 patients with severe pneumonia who were treated with BDB-001, an anti-C5a antibody produced by the company's licensee Beijing Defengrei Biotechnology in China.

IFX-1 is in development to treat inflammatory conditions such as hidradenitis suppurativa, ANCA-associated vasculitis, and pyoderma gangraenosum. IFX-1, in combination with Merck's anti-PD-1 therapy, Keytruda is being evaluated in patients with an undisclosed tumor type.

Nachrichten zu InflaRx N.V. Registered Shsmehr Nachrichten

Analysen zu InflaRx N.V. Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

InflaRx N.V. Registered Shs 1,38 -7,25% InflaRx N.V. Registered Shs